-
1
-
-
0026543487
-
Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5
-
published erratum appears in Exp Hematol 1992 May;20(4):531
-
(1992)
Exp Hematol
, vol.20
, pp. 223-228
-
-
King, A.G.1
Talmadge, J.E.2
Badger, A.M.3
-
3
-
-
0028070910
-
+ human hematopoietic progenitor cells
-
(1994)
J Exp Med
, vol.180
, pp. 1177-1182
-
-
Snoeck, H.W.1
Van-Bockstaele, D.R.2
Nys, G.3
Lenjou, M.4
Lardon, F.5
Haenen, L.6
Rodrigus, I.7
Peetermans, M.E.8
-
12
-
-
0027731190
-
The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors
-
(1993)
Stem Cells
, vol.11
, pp. 455-464
-
-
Grillon, C.1
Bonnet, D.2
Mary, J.Y.3
Lenfant, M.4
Najman, A.5
Guigon, M.6
-
13
-
-
0026500752
-
The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells
-
(1992)
Exp Hematol
, vol.20
, pp. 251-255
-
-
Bonnet, D.1
Cesaire, R.2
Lemoine, F.3
Aoudjhane, M.4
Najman, A.5
Guigon, M.6
-
14
-
-
0028022981
-
The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: Evidence for an indirect mechanism
-
(1994)
Blood
, vol.84
, pp. 1534-1542
-
-
Cashman, J.D.1
Eaves, A.C.2
Eaves, C.J.3
-
15
-
-
0027941369
-
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B
-
(1994)
N Engl J Med
, vol.331
, pp. 896-903
-
-
Mayer, R.J.1
Davis, R.B.2
Schiffer, C.A.3
Berg, D.T.4
Powell, B.L.5
Schulman, P.6
Omura, G.A.7
Moore, J.O.8
McIntyre, O.R.9
Frei, E.10
-
16
-
-
0028274962
-
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma
-
published erratum appears in N Engl J Med 1994 Jul 14;331(2):139
-
(1994)
N Engl J Med
, vol.330
, pp. 1253-1259
-
-
Wood, W.C.1
Budman, D.R.2
Korzun, A.H.3
Cooper, M.R.4
Younger, J.5
Hart, R.D.6
Moore, A.7
Ellerton, J.A.8
Norton, L.9
Ferree, C.R.10
-
17
-
-
0345131723
-
Elderly patients with aggressive nonHodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: Identification of two age subgroups with differing hematologic toxicity
-
(1998)
J Clin Oncol
, vol.16
, pp. 2352-2358
-
-
Gomez, H.1
Mas, L.2
Casanova, L.3
Pen, D.L.4
Santillana, S.5
Valdivia, S.6
Otero, J.7
Rodriguez, W.8
Carracedo, C.9
Vallejos, C.10
-
20
-
-
0029975460
-
In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation
-
(1996)
Exp Hematol
, vol.24
, pp. 713-721
-
-
Watanabe, T.1
Brown, G.S.2
Kelsey, L.S.3
Yan, Y.4
Jackson, J.D.5
Ewel, C.6
Kessinger, A.7
-
23
-
-
0029665492
-
Thymosin beta4, inhibitor for normal hematopoietic progenitor cells
-
(1996)
Exp Hematol
, vol.24
, pp. 776-782
-
-
Bonnet, D.1
Lemoine, F.M.2
Frobert, Y.3
Bonnet, M.L.4
Baillou, C.5
Najman, A.6
Guigon, M.7
-
24
-
-
0031040631
-
Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells
-
(1997)
Exp Hematol
, vol.25
, pp. 140-146
-
-
Li, J.1
Volkov, L.2
Comte, L.3
Herve, P.4
Praloran, V.5
Charbord, P.6
-
26
-
-
0031970707
-
Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF
-
(1998)
Int J Cancer
, vol.76
, pp. 38-46
-
-
Bogden, A.E.1
Moreau, J.P.2
Gamba, V.C.3
Deschamps-de, P.E.4
Tubiana, M.5
Frindel, E.6
Carde, P.7
-
28
-
-
0031962948
-
The tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects from doxorubicin-induced toxicity: Improvement in mice survival and protection of bone marrow stem cells and progenitors
-
(1998)
Blood
, vol.91
, pp. 441-449
-
-
Masse, A.1
Ramirez, L.H.2
Bindoula, G.3
Grillon, C.4
Wdzieczak, B.J.5
Raddassi, K.6
Deschamps-de, P.E.7
Mencia, H.J.8
Koscielny, S.9
Potier, P.10
Sainteny, F.11
Carde, P.12
-
32
-
-
0030035025
-
The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654)
-
(1996)
Exp Hematol
, vol.24
, pp. 77-81
-
-
Genevay, M.C.1
Mormont, C.2
Thomas, F.3
|